Literature DB >> 16525050

An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability.

Arthur J Barela1, Salina P Waddy, Jay G Lickfett, Jessica Hunter, Aimee Anido, Sandra L Helmers, Alan L Goldin, Andrew Escayg.   

Abstract

Mutations in three voltage-gated sodium channel genes, SCN1A, SCN2A, and SCN1B, and two GABAA receptor subunit genes, GABRG2 and GABRD, have been identified in families with generalized epilepsy with febrile seizures plus (GEFS+). A novel mutation, R859C, in the Nav1.1 sodium channel was identified in a four-generation, 33-member Caucasian family with a clinical presentation consistent with GEFS+. The mutation neutralizes a positively charged arginine in the domain 2 S4 voltage sensor of the Nav1.1 channel alpha subunit. This residue is conserved in mammalian sodium channels as well as in sodium channels from lower organisms. When the mutation was placed in the rat Nav1.1 channel and expressed in Xenopus oocytes, the mutant channel displayed a positive shift in the voltage dependence of sodium channel activation, slower recovery from slow inactivation, and lower levels of current compared with the wild-type channel. Computational analysis suggests that neurons expressing the mutant channel have higher thresholds for firing a single action potential and for firing multiple action potentials, along with decreased repetitive firing. Therefore, this mutation should lead to decreased neuronal excitability, in contrast to most previous GEFS+ sodium channel mutations, which have changes predicted to increase neuronal firing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525050      PMCID: PMC6675156          DOI: 10.1523/JNEUROSCI.2977-05.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

1.  Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus.

Authors:  R H Wallace; I E Scheffer; S Barnett; M Richards; L Dibbens; R R Desai; T Lerman-Sagie; D Lev; A Mazarib; N Brand; B Ben-Zeev; I Goikhman; R Singh; G Kremmidiotis; A Gardner; G R Sutherland; A L George; J C Mulley; S F Berkovic
Journal:  Am J Hum Genet       Date:  2001-03-13       Impact factor: 11.025

2.  Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2.

Authors:  A Escayg; B T MacDonald; M H Meisler; S Baulac; G Huberfeld; I An-Gourfinkel; A Brice; E LeGuern; B Moulard; D Chaigne; C Buresi; A Malafosse
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

Review 3.  From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

4.  A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation.

Authors:  S Bendahhou; T R Cummins; A F Hahn; S Langlois; S G Waxman; L J Ptácek
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

Authors:  L Claes; J Del-Favero; B Ceulemans; L Lagae; C Van Broeckhoven; P De Jonghe
Journal:  Am J Hum Genet       Date:  2001-05-15       Impact factor: 11.025

6.  First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene.

Authors:  S Baulac; G Huberfeld; I Gourfinkel-An; G Mitropoulou; A Beranger; J F Prud'homme; M Baulac; A Brice; R Bruzzone; E LeGuern
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

7.  Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures.

Authors:  R H Wallace; C Marini; S Petrou; L A Harkin; D N Bowser; R G Panchal; D A Williams; G R Sutherland; J C Mulley; I E Scheffer; S F Berkovic
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

8.  A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction.

Authors:  T Sugawara; Y Tsurubuchi; K L Agarwala; M Ito; G Fukuma; E Mazaki-Miyazaki; H Nagafuji; M Noda; K Imoto; K Wada; A Mitsudome; S Kaneko; M Montal; K Nagata; S Hirose; K Yamakawa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

9.  A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy.

Authors:  A Escayg; A Heils; B T MacDonald; K Haug; T Sander; M H Meisler
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

10.  Role of domain 4 in sodium channel slow inactivation.

Authors:  N Mitrovic; A L George; R Horn
Journal:  J Gen Physiol       Date:  2000-06       Impact factor: 4.086

View more
  29 in total

Review 1.  Translational regulation of neuronal electrical properties.

Authors:  Andrew J Weston; Richard A Baines
Journal:  Invert Neurosci       Date:  2007-01-13

2.  (What to do) when epilepsy gene mutations stop making sense.

Authors:  Edward C Cooper
Journal:  Epilepsy Curr       Date:  2007 Jan-Feb       Impact factor: 7.500

3.  Generation and customization of biosynthetic excitable tissues for electrophysiological studies and cell-based therapies.

Authors:  Hung X Nguyen; Robert D Kirkton; Nenad Bursac
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

4.  Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus.

Authors:  Verena C Wimmer; Christopher A Reid; Suzanne Mitchell; Kay L Richards; Byron B Scaf; Bryan T Leaw; Elisa L Hill; Michel Royeck; Marie-Therese Horstmann; Brett A Cromer; Philip J Davies; Ruwei Xu; Holger Lerche; Samuel F Berkovic; Heinz Beck; Steven Petrou
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

5.  Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

Authors:  Miguel Fribourg; José L Moreno; Terrell Holloway; Davide Provasi; Lia Baki; Rahul Mahajan; Gyu Park; Scott K Adney; Candice Hatcher; José M Eltit; Jeffrey D Ruta; Laura Albizu; Zheng Li; Adrienne Umali; Jihyun Shim; Alexandre Fabiato; Alexander D MacKerell; Vladimir Brezina; Stuart C Sealfon; Marta Filizola; Javier González-Maeso; Diomedes E Logothetis
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

6.  Nav 1.1 dysfunction in genetic epilepsy with febrile seizures-plus or Dravet syndrome.

Authors:  Linda Volkers; Kristopher M Kahlig; Nienke E Verbeek; Joost H G Das; Marjan J A van Kempen; Hans Stroink; Paul Augustijn; Onno van Nieuwenhuizen; Dick Lindhout; Alfred L George; Bobby P C Koeleman; Martin B Rook
Journal:  Eur J Neurosci       Date:  2011-08-22       Impact factor: 3.386

Review 7.  Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities.

Authors:  Shawn McClelland; Céline M Dubé; Jaqueline Yang; Tallie Z Baram
Journal:  Neurosci Lett       Date:  2011-02-26       Impact factor: 3.046

8.  SCN1A, SCN1B, and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.

Authors:  Huihui Sun; Yuehua Zhang; Jianmin Liang; Xiaoyan Liu; Xiuwei Ma; Husheng Wu; Keming Xu; Jiong Qin; Yu Qi; Xiru Wu
Journal:  J Hum Genet       Date:  2008-06-20       Impact factor: 3.172

9.  Target-specific IPSC kinetics promote temporal processing in auditory parallel pathways.

Authors:  Ruili Xie; Paul B Manis
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

10.  A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation.

Authors:  Bin Tang; Karoni Dutt; Ligia Papale; Raffaella Rusconi; Anupama Shankar; Jessica Hunter; Sergio Tufik; Frank H Yu; William A Catterall; Massimo Mantegazza; Alan L Goldin; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2009-05-03       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.